Sumavel DosePro was approved in 2009 for the acute treatment of migraine or cluster headaches as a needle-free delivery system supplied in prefilled pens, and is being discontinued.
Nasal sumatriptan powder was associated with more favorable nausea outcomes compared with oral sumatriptan tablets in patients with acute migraine.
The use of intranasal sumatriptan is an effective treatment for patients with acute migraine attacks; however, future investigations are needed to better understand differences in routes of administration and other therapies for migraine.
Nasal administration of sumatriptan powder in patients with migraine results in quicker reductions in pain intensity and migraine-related disability compared with oral sumatriptan.
Nasal delivery provides rapid relief
Clinical Pain Advisor Articles
- Safety, Efficacy of Lidocaine Infusion for Prolonged Neuropathic Pain
- Assessing the Efficacy of Low-Dose Amitriptyline for Idiopathic Chronic Neck Pain
- CBT vs Pain Education for Chronic Pain in Low-Income Clinics
- Non-Opioid Therapies for Pain Management in the ED
- Trigger Point Dry Needling Plus Exercise Cost-Effective for Subacromial Pain Syndrome
- Exploring the Connections Between Neuropathic Pain and Comorbid Mood Disorders
- Medical Marijuana Laws, Dispensaries May Reduce Deaths From Opioid Overdose
- Ketamine Infusion May Be Effective for the Short-Term Relief of CRPS-Associated Pain
- An Avenue for the Development of Opioid Adjuncts for Enhanced Analgesia, Reduced Abuse Potential
- Spinal Manipulative Therapy May Effectively Reduce Cervicogenic Headache Days
- Chronic Pain in Adolescents and Alexithymia
- Bedside Quantitative Sensory Testing May Reliably Assess Sensory Profiles in Neuropathic Pain
- Peripheral Neuropathy Management in the Primary Care Setting: A Guide
- The Link Between Medical Malpractice and Defensive Medicine
- Drug Copayments Often Exceed Prescription Drug Costs